TGen, a part of City of Hope, is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments.
Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics and treatments for cancer, neurological disorders, rare childhood disorders, infectious disease and other complex conditions.
Stay up-to-date: tgen.org/subscribe
Company Details
- Employees
- 408
- Founded
- -
- Address
- 445 N. Fifth Street,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.tgen.org
- Keywords
- Genomics, Research, Translational Medicine, Education, Neurological Disorders, Pathogens and Microbiome, Metabolic and Fibrotic Diseases, Next Generation Technology, Artificial Intelligence, Alzheimer's Disease, Pancreatic Cancer, Brain Cancer, Breast Cancer, Rare Disorders, Ovarian Cancer, Precision Aging, Infectious Disease, Diabetes.
- HQ
- Phoenix, AZ
Tgen - Part Of City Of Hope Questions
Tgen - Part Of City Of Hope's website is http://www.tgen.org
Tgen - Part Of City Of Hope's LinkedIn profile is https://www.linkedin.com/company/tgenresearch
Tgen - Part Of City Of Hope has
408 employees.
View email and phone details for 408
employees at Tgen - Part Of City Of Hope.
Tgen - Part Of City Of Hope's industry is
Biotechnology Research
Tgen - Part Of City Of Hope's top competitors are
Kaligent - Part Of Tgen,
Phoenix Children's,
Barrow Neurological Institute,
Exact Sciences,
City Of Hope,
Caris Life Sciences,
Mayo Clinic,
Myriad Genetics,
Cancer Treatment Centers Of America (Acquired By City Of Hope),
Illumina.
Tgen - Part Of City Of Hope's categories are Biotechnology Research
Tgen - Part Of City Of Hope's founding year is 2002
